The Intercept @theintercept
Mylan, which raised the cost of EpiPens by 400%, has virtually no competition. They control 87% of the U.S. market. https://t.co/r5ZM9Ro9Vv — PolitiTweet.org
Created
Wed Aug 24 20:38:24 +0000 2016
Likes
115
Retweets
214
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
The Intercept @theintercept
Mylan, which raised the cost of EpiPens by 400%, has virtually no competition. They control 87% of the U.S. market. https://t.co/r5ZM9Ro9Vv — PolitiTweet.org